Author headshot

Stephen J. Schuster, MD

Schuster is director of the lymphoma program and lymphoma translational research at Abramson Cancer Center, as well as Robert and Margarita Louis-Dreyfus professor in chronic lymphocytic leukemia and lymphoma clinical care at University of Pennsylvania’s Perelman School of Medicine.

Most recent by Stephen J. Schuster, MD

SPONSORED CONTENT
October 04, 2022
6 min read
Save

CAR-T has ‘fundamentally changed’ outcomes in follicular lymphoma

Follicular lymphoma is among the least common types of non-Hodgkin lymphoma, but the nature of the disease has allowed those who require treatment to benefit from the groundbreaking development of chimeric antigen receptor T cells.

SPONSORED CONTENT
October 04, 2022
6 min read
Save

CAR-T has ‘fundamentally changed’ outcomes in follicular lymphoma

Follicular lymphoma is among the least common types of non-Hodgkin lymphoma, but the nature of the disease has allowed those who require treatment to benefit from the groundbreaking development of chimeric antigen receptor T cells.

SPONSORED CONTENT
March 13, 2018
2 min watch
Save

VIDEO: CAR T cells effective for non-Hodgkin lymphoma

NEW YORK — In this video commentary from HemOnc Today New York, Stephen J. Schuster, MD, discusses treatment with CD19-directed chimeric antigen receptor T cells for non-Hodgkin lymphoma.